Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-05

Clinical Trial Update: A Trial of SHR-4849 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Clinical trial update for SHR-4849 in advanced solid tumors describing a Phase 1 study that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR-4849 (SHR-4849)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING